{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:58:32Z","timestamp":1783101512274,"version":"3.54.6"},"reference-count":31,"publisher":"BMJ","issue":"2","funder":[{"DOI":"10.13039\/501100001511","name":"Auckland Medical Research Foundation","doi-asserted-by":"publisher","award":["1110009"],"award-info":[{"award-number":["1110009"]}],"id":[{"id":"10.13039\/501100001511","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001518","name":"Maurice and Phyllis Paykel Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["09\/095"],"award-info":[{"award-number":["09\/095"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Rebecca Roberts"},{"DOI":"10.13039\/501100001529","name":"Waikato Medical Research Foundation","doi-asserted-by":"publisher","award":["171"],"award-info":[{"award-number":["171"]}],"id":[{"id":"10.13039\/501100001529","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health","doi-asserted-by":"crossref","award":["R01HD0692201"],"award-info":[{"award-number":["R01HD0692201"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child Fetal Neonatal Ed"],"accepted":{"date-parts":[[2022,7,20]]},"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Dextrose gel is used to treat neonatal hypoglycaemia, but later effects are unknown.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design and setting<\/jats:title>\n                  <jats:p>Follow-up of participants in a randomised trial recruited in a tertiary centre and assessed in a research clinic.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients<\/jats:title>\n                  <jats:p>Children who were hypoglycaemic (&lt;2.6 mmol\/L) recruited to the Sugar Babies Study (<jats:underline>&gt;<\/jats:underline>35 weeks, &lt;48 hours old) and randomised to treatment with 40% dextrose or placebo gel.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Interventions<\/jats:title>\n                  <jats:p>Assessment of neurological status, cognitive ability (Weschler Preschool and Primary Scale of Intelligence), executive function (five tasks), motor function (Movement Assessment Battery for Children-2 (MABC-2)), vision, visual processing (Beery-Buktenica Development Test of Visual Motor Integration (Beery VMI) and motion coherence thresholds) and growth at 2 years.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main outcome measures<\/jats:title>\n                  <jats:p>Neurosensory impairment (cerebral palsy; visual impairment; deafness; intelligence quotient &lt;85; Beery VMI &lt;85; MABC-2 score &lt;15th centile; low performance on executive function or motion coherence).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 237 babies randomised, 185 (78%) were assessed; 96 randomised to dextrose and 89 to placebo gel. Neurosensory impairment was similar in both groups (dextrose 36\/96 (38%) vs placebo 34\/87 (39%), relative risk 0.96, 95% CI 0.66 to 1.34, p=0.83). Secondary outcomes were also similar, except children randomised to dextrose had worse visual processing scores (mean (SD) 94.5 (15.9) vs 99.8 (15.9), p=0.02) but no differences in the proportion with visual processing scores &lt;85 or other visual test scores. Children randomised to dextrose gel were taller (z-scores 0.18 (0.97) vs \u22120.17 (1.01), p=0.001) and heavier (0.57 (1.07) vs 0.29 (0.92), p=0.01).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Treatment of neonatal hypoglycaemia (&lt;2.6 mol\/L) with dextrose gel does not alter neurosensory impairment at 4.5 years. However, further assessment of visual processing and growth may be warranted.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>ACTRN1260800062392.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/archdischild-2022-324148","type":"journal-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T13:25:15Z","timestamp":1659965115000},"page":"121-128","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Outcome at 4.5 years after dextrose gel treatment of hypoglycaemia: follow-up of the Sugar Babies randomised trial"],"prefix":"10.1136","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2498-9223","authenticated-orcid":false,"given":"Deborah L","family":"Harris","sequence":"first","affiliation":[{"name":"School of Nursing Midwifery and Health Practice, Victoria University of Wellington, Wellington, New Zealand"},{"name":"Liggins Institute, The University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg D","family":"Gamble","sequence":"additional","affiliation":[{"name":"Liggins Institute, The University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2697-1422","authenticated-orcid":false,"given":"Jane E","family":"Harding","sequence":"additional","affiliation":[{"name":"Liggins Institute, The University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,8,8]]},"reference":[{"key":"2025090513252354000_108.2.121.1","doi-asserted-by":"publisher","DOI":"10.1159\/000492859"},{"key":"2025090513252354000_108.2.121.2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-3851"},{"key":"2025090513252354000_108.2.121.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2015.03.057"},{"key":"2025090513252354000_108.2.121.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61645-1"},{"key":"2025090513252354000_108.2.121.5","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2017-312772"},{"key":"2025090513252354000_108.2.121.6","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1111\/1552-6909.12614","article-title":"Use of dextrose gel reverses neonatal hypoglycemia and decreases admissions to the NICU","volume":"44","author":"Bennett","year":"2015","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"2025090513252354000_108.2.121.7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000448511","article-title":"Oral dextrose gel reduces the need for intravenous dextrose therapy in neonatal hypoglycemia","volume":"1","author":"Rawat","year":"2016","journal-title":"Biomed Hub"},{"key":"2025090513252354000_108.2.121.8","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/jpc.13409","article-title":"Implementation of dextrose gel in the management of neonatal hypoglycaemia","volume":"53","author":"Ter","year":"2017","journal-title":"J Paediatr Child Health"},{"key":"2025090513252354000_108.2.121.9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jpeds.2018.02.036","article-title":"Cost analysis of treating neonatal hypoglycemia with dextrose gel","volume":"198","author":"Glasgow","year":"2018","journal-title":"J Pediatr"},{"key":"2025090513252354000_108.2.121.10","unstructured":"British Association of Perinatal Medicine . Identification and management of neonatal hypoglycaemia in the full term infant \u2013 a framework for practice. London: British Association of Perinatal Medicine, 2017."},{"key":"2025090513252354000_108.2.121.11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/0890334419846128","article-title":"Identification and management of neonatal hypoglycemia in the full-term infant. British association of perinatal medicine framework for practice, 2017","volume":"35","author":"Hawdon","year":"2019","journal-title":"J Hum Lact"},{"key":"2025090513252354000_108.2.121.12","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/pxz134"},{"key":"2025090513252354000_108.2.121.13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/apa.14955","article-title":"Swedish national guideline for prevention and treatment of neonatal hypoglycaemia in newborn infants with gestational age \u226535 weeks","volume":"109","author":"Wackernagel","year":"2020","journal-title":"Acta Paediatr"},{"key":"2025090513252354000_108.2.121.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2018.12.004"},{"key":"2025090513252354000_108.2.121.15","unstructured":"Queensland Clinical Guidelines . Hypoglycaemia-newborn, 2019. Available: http:\/\/www.health.qld.gov.au\/qcg [Accessed 12 Apr 2020]."},{"key":"2025090513252354000_108.2.121.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2015.10.066"},{"key":"2025090513252354000_108.2.121.17","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/jamapediatrics.2017.1579","article-title":"Association of neonatal glycemia with neurodevelopmental outcomes at 4.5 years","volume":"171","author":"McKinlay","year":"2017","journal-title":"JAMA Pediatr"},{"key":"2025090513252354000_108.2.121.18","doi-asserted-by":"crossref","unstructured":"Gioia G , Isquith P , Guy S , et al . BRIEF: Behavior Rating Inventory of Executive Function - Professional Manual. Odessa, FL: Psychological Assessment Resources, 2000.","DOI":"10.1037\/t73087-000"},{"key":"2025090513252354000_108.2.121.19","doi-asserted-by":"crossref","unstructured":"Henderson S , Sugden D , Barnett A . Movement assessment battery for children-2. London, UK: Harcourt Assessment, 2007.","DOI":"10.1037\/t55281-000"},{"key":"2025090513252354000_108.2.121.20","doi-asserted-by":"crossref","unstructured":"Beery KE , Beery NA . The Beery-Buktenica development test of visual-motor integration. 6th edn. Bloomington, Minn: Pearson, 2010.","DOI":"10.1037\/t48947-000"},{"key":"2025090513252354000_108.2.121.21","unstructured":"Phelps L . Phelps kindergarten readiness scale manual. 2nd ed. Brandon, VT: Psychological Press, 2003."},{"key":"2025090513252354000_108.2.121.22","unstructured":"Ministry of Health New Zealand . Measuring and plotting, 2010. Available: https:\/\/www.health.govt.nz\/system\/files\/documents\/pages\/factsheet-3-growth-charts-well-child.pdf [Accessed 16 Oct 2016]."},{"key":"2025090513252354000_108.2.121.23","unstructured":"World Health Organization . WHO child growth standards: length\/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development, 2006. Available: https:\/\/www.who.int\/publications\/i\/item\/924154693X [Accessed 12 Apr. 2001]."},{"key":"2025090513252354000_108.2.121.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7610.1997.tb01545.x"},{"key":"2025090513252354000_108.2.121.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.1996.tb00939.x"},{"key":"2025090513252354000_108.2.121.26","unstructured":"Rutter M , Bailey A , Lord C . Social communication questionnaire. Torrance, CA: Western Psychological Services, 2003."},{"key":"2025090513252354000_108.2.121.27","unstructured":"Atkinson J , Salmond C , Crampton P . NZDep2013 index of deprivation. Dunedin, NZ: Department of Public Health, University of Otago, 2014."},{"key":"2025090513252354000_108.2.121.28","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.634305","article-title":"Neonatal hypoglycemia and brain vulnerability","volume":"12","author":"De Angelis","year":"2021","journal-title":"Front Endocrinol"},{"key":"2025090513252354000_108.2.121.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2016.12.009"},{"key":"2025090513252354000_108.2.121.30","doi-asserted-by":"publisher","DOI":"10.1203\/01.PDR.0000036602.81878.6D"},{"key":"2025090513252354000_108.2.121.31","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-001040"}],"container-title":["Archives of Disease in Childhood - Fetal and Neonatal Edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2022-324148","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T20:25:36Z","timestamp":1757103936000},"score":1,"resource":{"primary":{"URL":"https:\/\/fn.bmj.com\/lookup\/doi\/10.1136\/archdischild-2022-324148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,8]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2,17]]},"published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1136\/archdischild-2022-324148"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2022-324148","relation":{},"ISSN":["1359-2998","1468-2052"],"issn-type":[{"value":"1359-2998","type":"print"},{"value":"1468-2052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,8]]}}}